secwatch.observer — SEC 8-K summary
======================================

Issuer:     HYPERION DEFI, INC. (HYPD)
CIK:        0001682639
Form:       8-K
Filed at:   2024-04-09T23:59:59+00:00
Accession:  0001104659-24-045015
Event type: other_material
Sentiment:  negative
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eyenovia raises ~$2.0M in registered direct offering at $0.6204/share
---------------------------------------------------------------------

- Sold 3,223,726 shares at $0.6204/share to a single healthcare investor; gross proceeds ~$2.0M.
- Net proceeds to fund commercialization of Mydcombi and clobetasol propionate, complete CHAPERONE study.
- Offering expected to close on or about April 11, 2024, subject to customary conditions.
- Shares issued under existing effective shelf registration statement (No. 333-261638).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682639/000110465924045015/0001104659-24-045015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682639/000110465924045015/tm2411385d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-045015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer